Description

Nitrogranulong tablets with prolonged release 2.9 mg №50

Ingredients:

Each tablet contains 2.9 mg of Nitrogranulong with prolonged release.

Dosage:

The recommended dosage is one tablet per day, or as directed by a healthcare professional.

Indications:

Nitrogranulong tablets are indicated for the prevention and treatment of angina pectoris.

Contraindications:

Do not use Nitrogranulong tablets if you are allergic to any of the ingredients. Consult your doctor before use if you have hypotension or severe anemia.

Directions:

Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.

Scientific Evidence:

Nitrogranulong tablets with prolonged release 2.9 mg have been studied in clinical trials to assess their efficacy in the management of angina pectoris. Research published in the Journal of Cardiology demonstrated that nitroglycerin, the active ingredient in Nitrogranulong, effectively reduces the frequency and severity of angina attacks.

Additional Information:

Nitrogranulong tablets provide a sustained release of nitroglycerin, ensuring a continuous therapeutic effect over an extended period. This formulation helps maintain consistent nitric oxide levels in the body, leading to vasodilation and improved blood flow to the heart muscle. Clinical studies have shown that prolonged-release nitroglycerin formulations like Nitrogranulong offer better symptom control and enhanced quality of life for patients with angina.